Your browser doesn't support javascript.
loading
Moving Beyond 3+3: The Future of Clinical Trial Design.
Kurzrock, Razelle; Lin, Chia-Chi; Wu, Tsung-Che; Hobbs, Brian P; Pestana, Roberto Carmagnani; Hong, David S.
Affiliation
  • Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego, Moores Cancer Center, La Jolla, CA.
  • Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Wu TC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Hobbs BP; Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, TX.
  • Pestana RC; Centro de Oncologia e Hematologia Einstein Familia Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Hong DS; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Am Soc Clin Oncol Educ Book ; 41: e133-e144, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34061563
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Neoplasms Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Am Soc Clin Oncol Educ Book Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Neoplasms Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Am Soc Clin Oncol Educ Book Year: 2021 Document type: Article Affiliation country: Country of publication: